Table 2. Semi-quantitative analysis of targeted marker expression IPF and COP.
PMC markers | Honeycombing in IPF or epithelial cells surrounding fibrous tufts in COP | Fibroblastic foci in IPF or fibrotic area in COP | ||||
---|---|---|---|---|---|---|
IPF | COP | P value | IPF | COP | P value | |
LRRN4 | 2.41 ± 0.59 | 0.33 ± 0.50 | < 0.001 | 2.30 ± 0.73 | 0.55 ± 0.52 | < 0.001 |
UPK3B | 1.00 ± 0.72 | 0.55 ± 0.66 | 0.111 | 0.45 ± 0.51 | 0.77 ± 0.66 | 0.157 |
CCL18 | 1.75 ± 1.07 | 0.77 ± 0.97 | 0.027 | 0.35 ± 0.87 | 0.0 ± 0.0 | 0.245 |
Laminin-5 | 1.35 ± 0.58 | 1.77 ± 0.83 | 0.123 | 0.85 ± 0.48 | 1.66 ± 0.86 | < 0.003 |
Data are presented as mean expression score ± standard deviation.
IPF = idiopathic pulmonary fibrosis, COP = cryptogenic organizing pneumonia, PMC = pleural mesothelial cell, LRRN4 = leucine rich repeat neuronal 4, UPK3B = uroplakin 3b, CCL18 = CC-chemokine ligand 18.